Skip to content

Henry Schein HSIC Net additions (releases) charged to costs and expenses

Net additions (releases) charged to costs and expenses at other companies

Medline, Inc.
 logo
Medline, Inc. MDLN
Globus Medical logo
Globus MedicalGMED
Medtronic logo
MedtronicMDT
Baxter International logo
Baxter InternationalBAX

Other financials

Income statement

See full
Revenue$3.4B+6.3%
Gross profit$1.1B+7.0%
Operating income$182.0M+4.0%
Net income$107.0M-2.7%
EPS (diluted)$0.92+4.5%

Balance sheet

See full
Cash & equivalents$138.0M+8.7%
Total debt$3.7B+17.2%
Total equity$3.3B-1.3%
Total assets$11.3B+7.9%

Cash flow

See full
Operating cash flow-$97.0M-362%
CapEx$25.0M-19.4%
Free cash flow-$122.0M-2,133%

Valuation

See full
Market cap$9.1B-0.6%
Enterprise value$12.69B+4.2%
P/E23.1×+0.5×
P/S0.7×0.0×

Profitability

See full
Gross margin31.2%-0.4pp
Operating margin4.9%-0.2pp
Net margin3%-0.3pp
FCF margin3.3%-1.0pp

Returns & leverage

See full
Return on equity12%+0.2pp
Debt / equity1.1×+0.2×
Current ratio1.4×0.0×

Where this comes from

Reported directly by Henry Schein in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The official record: Henry Schein’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Henry Schein's net additions (releases) charged to costs and expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Henry Schein's net additions (releases) charged to costs and expenses?
Henry Schein (HSIC) reported net additions (releases) charged to costs and expenses of $6M in Q1 2026.
How has Henry Schein's net additions (releases) charged to costs and expenses changed year-over-year?
Henry Schein's net additions (releases) charged to costs and expenses increased by 200.0% year-over-year, from $2M to $6M.
What is the long-term trend for Henry Schein's net additions (releases) charged to costs and expenses?
Over 3 years (2022 to 2025), Henry Schein's net additions (releases) charged to costs and expenses has grown at a 47.4% compound annual growth rate (CAGR), from $5M to $16M.